Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities

June 22, 2026 12:27 PM

BofA Securities analyst Tazeen Ahmad raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $10.00 (from $9.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found